Skip to main content

Advertisement

Log in

Mastitis associated with Sjögren’s syndrome: a series of nine cases

  • Therapeutic Aspects in Autoimmunity
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Sjögren’s syndrome is well known to target exocrine glands, especially lacrimal and salivary glands, which share with mammary glands anatomical, histological, and immunological features. Herein, we investigated the mammary involvement in patients with Sjögren’s syndrome and compared the histological findings with minor salivary gland involvement. We reviewed the charts of patients with Sjögren’s syndrome (followed in Montpellier University Hospital, between January 2000 and January 2015), in whom minor salivary gland and mammary tissues were available. Two expert pathologists analysed retrospectively these tissues in order to identify inflammatory patterns. Immunohistochemical stainings were performed to precise leucocyte distribution. Sixteen Sjögren’s syndrome patients with available salivary and breast tissue samples were included. All were women, with a median age of 60.1 ± 11.3 years at Sjögren’s syndrome diagnosis. Mammary biopsy was conducted because of breast symptoms in 6 patients and following imaging screening strategies for breast cancer in 10 patients. Nine patients exhibited an inflammatory breast pattern (lymphocytic infiltrates or duct ectasia), close to minor salivary gland histological findings. Immunohistochemical stainings (n = 5) revealed B and T cell infiltrates within breast tissue, with a higher proportion of T CD4+ cells, but no IgG4-secreting plasma cells were found. This is the first series to describe breast inflammatory patterns in Sjögren’s syndrome. Mastitis is in line with the classical involvement of exocrine glands in this disease. These findings are consistent with the literature data considering Sjögren’s syndrome as an “autoimmune epithelitis”.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Burbelo PD, Ambatipudi K, Alevizos I. Genome-wide association studies in Sjögren’s syndrome: What do the genes tell us about disease pathogenesis? Autoimmun Rev. 2014;13:756–61. doi:10.1016/j.autrev.2014.02.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kivity S, Arango MT, Ehrenfeld M, Tehori O, Shoenfeld Y, Anaya J-M, et al. Infection and autoimmunity in Sjogren’s syndrome: a clinical study and comprehensive review. J Autoimmun. 2014;51:17–22. doi:10.1016/j.jaut.2014.02.008.

    Article  CAS  PubMed  Google Scholar 

  3. Boisserie P, Poupard A, Guntz M, Lafargue JP, Boyer J, Joubaud F. Primary biliary cirrhosis, chronic pancreatitis and Gougerot-Sjögren syndrome (apropos of a case). Gastroentérol Clin Biol. 1983;7:641–2.

    CAS  PubMed  Google Scholar 

  4. Barreda F, Contardo C, León A, Navarrete J, Figueroa R, Attanasio F. Primary sclerosing cholangitis associated with Sjögren’s syndrome, retroperitoneal fibrosis and chronic pancreatitis. Report of a case. Rev Gastroenterol Perú Órgano Soc Gastroenterol Perú. 1989;9:106–14.

    CAS  Google Scholar 

  5. Moutsopoulos HM. Sjögren’s syndrome: autoimmune epithelitis. Clin Immunol Immunopathol. 1994;72:162–5.

    Article  CAS  PubMed  Google Scholar 

  6. Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM. The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjogren’s syndrome (autoimmune epithelitis). Lupus. 2006;15:255–61.

    Article  CAS  PubMed  Google Scholar 

  7. Tzioufas AG, Kapsogeorgou EK, Moutsopoulos HM. Pathogenesis of Sjögren’s syndrome: what we know and what we should learn. J Autoimmun. 2012;39:4–8. doi:10.1016/j.jaut.2012.01.002.

    Article  CAS  PubMed  Google Scholar 

  8. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Shiboski SC, Shiboski CH, Criswell LA, Baer AN, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res. 2012;64:475–87.

    Article  CAS  Google Scholar 

  10. Lwin KY, Zuccarini O, Sloane JP, Beverley PC. An immunohistological study of leukocyte localization in benign and malignant breast tissue. Int J Cancer J Int Cancer. 1985;36:433–8.

    Article  CAS  Google Scholar 

  11. Degnim AC, Brahmbhatt RD, Radisky DC, Hoskin TL, Stallings-Mann M, Laudenschlager M, et al. Immune cell quantitation in normal breast tissue lobules with and without lobulitis. Breast Cancer Res Treat. 2014;144:539–49. doi:10.1007/s10549-014-2896-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Adamson TC, Fox RI, Frisman DM, Howell FV. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren’s syndrome using monoclonal antibodies. J Immunol Baltim Md. 1950;1983(130):203–8.

    Google Scholar 

  13. Huguet P, Bosch JA, Raventós A, Jacas C, Sanjosé A, Vilardell M. Sjögren’s syndrome: histologic and immunohistochemical study. Ann Méd Interne. 1995;146:233–4.

    CAS  Google Scholar 

  14. Garnier A. Analyse morphologique des critères diagnostiques du syndrome de Goujerot-Sjögren sur les biopsies de glandes salivaires accessoires: a propos de 90 cas. Faculté de Médecine de Limoges. (1996).

  15. Szabo K, Papp G, Dezso B, Zeher M. The histopathology of labial salivary glands in primary Sjögren’s syndrome: focusing on follicular helper T cells in the inflammatory infiltrates. Mediators Inflamm. 2014;. doi:10.1155/2014/631787.

    PubMed  PubMed Central  Google Scholar 

  16. Development Petherick A. Mother’s milk: a rich opportunity. Nature. 2010;468:S5–7. doi:10.1038/468S5a.

    Article  Google Scholar 

  17. Collado MC, Laitinen K, Salminen S, Isolauri E. Maternal weight and excessive weight gain during pregnancy modify the immunomodulatory potential of breast milk. Pediatr Res. 2012;72:77–85. doi:10.1038/pr.2012.42.

    Article  CAS  PubMed  Google Scholar 

  18. Aitken SL, Corl CM, Sordillo LM. Immunopathology of mastitis: insights into disease recognition and resolution. J Mammary Gland Biol Neoplasia. 2011;16:291–304. doi:10.1007/s10911-011-9230-4.

    Article  PubMed  Google Scholar 

  19. Boullu S, Andrac L, Piana L, Darmon P, Dutour A, Oliver C. Diabetic mastopathy, complication of type 1 diabetes mellitus: report of two cases and a review of the literature. Diabetes Metab. 1998;24:448–54.

    CAS  PubMed  Google Scholar 

  20. Kudva YC, Reynolds C, O’Brien T, Powell C, Oberg AL, Crotty TB. “Diabetic mastopathy”, or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. Diabetes Care. 2002;25:121–6.

    Article  PubMed  Google Scholar 

  21. Kinonen C, Gattuso P, Reddy VB. Lupus mastitis: an uncommon complication of systemic or discoid lupus. Am J Surg Pathol. 2010;34:901–6. doi:10.1097/PAS.0b013e3181da00fb.

    Article  PubMed  Google Scholar 

  22. Rosa M, Mohammadi A. Lupus mastitis: a review. Ann Diagn Pathol. 2013;17:230–3. doi:10.1016/j.anndiagpath.2012.09.003.

    Article  PubMed  Google Scholar 

  23. Islam AD, Selmi C, Datta-Mitra A, Sonu R, Chen M, Gershwin ME, et al. The changing faces of IgG4-related disease: clinical manifestations and pathogenesis. Autoimmun Rev. 2015;14:914–22. doi:10.1016/j.autrev.2015.06.003.

    Article  CAS  PubMed  Google Scholar 

  24. Vasaitis L. IgG4-related disease: a relatively new concept for clinicians. Eur J Intern Med. 2016;27:1–9. doi:10.1016/j.ejim.2015.09.022.

    Article  CAS  PubMed  Google Scholar 

  25. Dite P, Novotny I, Trna J, Sevcikova A. Autoimmune pancreatitis. Best Pract Res Clin Gastroenterol. 2008;22:131–43. doi:10.1016/j.bpg.2007.10.014.

    Article  CAS  PubMed  Google Scholar 

  26. Cheuk W, Chan ACL, Lam W-L, Chow S-M, Crowley P, Lloydd R, et al. IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases. Am J Surg Pathol. 2009;33:1058–64. doi:10.1097/PAS.0b013e3181998cbe.

    Article  PubMed  Google Scholar 

  27. Ogura K, Matsumoto T, Aoki Y, Kitabatake T, Fujisawa M, Kojima K. IgG4-related tumour-forming mastitis with histological appearances of granulomatous lobular mastitis: comparison with other types of tumour-forming mastitis. Histopathology. 2010;57:39–45. doi:10.1111/j.1365-2559.2010.03581.x.

    Article  PubMed  Google Scholar 

  28. Herrera van Oostdam DA, Jaimes Piñón T, Martínez-Martínez MU, Oros-Ovalle C, Aléman-Sánchez N, Abud-Mendoza C. IgG4-related disease, retrospective histopathological diagnosis. Prevalence in an university hospital. Reumatol Clin. 2015;. doi:10.1016/j.reuma.2014.12.007.

    PubMed  Google Scholar 

  29. Chougule A, Bal A, Das A, Singh G. IgG4 related sclerosing mastitis: expanding the morphological spectrum of IgG4 related diseases. Pathology (Phila). 2015;47:27–33. doi:10.1097/PAT.0000000000000187.

    CAS  Google Scholar 

  30. Stappaerts I, Colpaert C, Verbraecken J, Van Marck E, Vermeire P. Granulomatous mastitis as presenting sign of Wegener’s granulomatosis. Acta Clin Belg. 1999;54:207–10.

    CAS  PubMed  Google Scholar 

  31. Ladefoged K, Balslev E, Jemec GB. Crohn’s disease presenting as a breast abscess: a case report. J Eur Acad Dermatol Venereol JEADV. 2001;15:343–5.

    CAS  PubMed  Google Scholar 

  32. Barczyńska T, Dankiewicz-Fares I, Bilińska-Reszkowska H, Zalewska J, Jeka S. Atypical location of Wegener’s granulomatosis with breast involvement: case report. Ann Acad Med Stetin. 2011;57:70–6.

    PubMed  Google Scholar 

  33. Zujić PV, Grebić D, Valenčić L. Chronic granulomatous inflammation of the breast as a first clinical manifestation of primary sarcoidosis. Breast Care Basel Switz. 2015;10:51–3. doi:10.1159/000370206.

    Article  Google Scholar 

  34. Rahal RMS, de Freitas-Júnior R, Carlos da Cunha L, Moreira MAR, Rosa VDL, Conde DM. Mammary duct ectasia: an overview. Breast J. 2011;17:694–5. doi:10.1111/j.1524-4741.2011.01166.x.

    Article  PubMed  Google Scholar 

  35. Al-Masad JK. Mammary duct ectasia and periductal mastitis in males. Saudi Med J. 2001;22:1030–3.

    CAS  PubMed  Google Scholar 

  36. Gregoir C, Hilliquin P, Acar F, Lessana-Leibowitch M, Renoux M, Menkès CJ. Acute mastitis in rheumatoid polyarthritis with Gougerot-Sjögren syndrome treated with tiopronin (Acadione). Rev Rhum Mal Ostéo Articul. 1991;58:203–6.

    CAS  Google Scholar 

  37. Valdez R, Thorson J, Finn WG, Schnitzer B, Kleer CG. Lymphocytic mastitis and diabetic mastopathy: a molecular, immunophenotypic, and clinicopathologic evaluation of 11 cases. Mod Pathol. 2003;16:223–8. doi:10.1097/01.MP.0000056627.21128.74.

    Article  PubMed  Google Scholar 

  38. Ríos G, Peredo RA. Lymphocytic mastitis preceding Sjögren’s syndrome. P R Health Sci J. 2010;29:127–9.

    PubMed  Google Scholar 

  39. Chomette G, Auriol M, Labrousse F, Raphaël M, Szpirglas H, Vaillant JM. Immunopathology of the labial salivary glands in Sjögren’s syndrome and other autoimmune diseases. Rev Stomatol Chir Maxillofac. 1988;89:237–41.

    CAS  PubMed  Google Scholar 

  40. Talal N, Asofsky R, Lightbody P. Immunoglobulin synthesis by salivary gland lymphoid cells in Sjögren’s syndrome. J Clin Invest. 1970;49:49–54. doi:10.1172/JCI106221.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Anderson LG, Cummings NA, Asofsky R, Hylton MB, Tarpley TM, Tomasi TB, et al. Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren’s syndrome. Natural history and response to treatment. Am J Med. 1972;53:456–63.

    Article  CAS  PubMed  Google Scholar 

  42. Speight PM, Cruchley A, Williams DM. Quantification of plasma cells in labial salivary glands: increased expression of IgM in Sjögren’s syndrome. J Oral Pathol Med. 1990;19:126–30.

    Article  CAS  PubMed  Google Scholar 

  43. Matthews JB, Deacon EM, Wilson C, Potts AJ, Hamburger J. Plasma cell populations in labial salivary glands from patients with and without Sjögren’s syndrome. Histopathology. 1993;23:399–407.

    Article  CAS  PubMed  Google Scholar 

  44. van Woerkom JM, Kruize AA, Barendregt PJ, Kater L, Hené R, Bootsma H, et al. Clinical significance of quantitative immunohistology in labial salivary glands for diagnosing Sjogren’s syndrome. Rheumatol Oxf Engl. 2006;45:470–7. doi:10.1093/rheumatology/kei191.

    Article  Google Scholar 

  45. Roguedas A-M, Pers J-O, Lemasson G, Devauchelle V, Tobón GJ, Saraux A, et al. Memory B-cell aggregates in skin biopsy are diagnostic for primary Sjögren’s syndrome. J Autoimmun. 2010;35:241–7. doi:10.1016/j.jaut.2010.06.014.

    Article  CAS  PubMed  Google Scholar 

  46. Yoshiiwa A, Nabata T, Morimoto S, Sakaguchi K, Yamagata H, Fukuo K, et al. A case of Hashimoto’s thyroiditis associated with renal tubular acidosis, Sjögren syndrome and empty sella syndrome. Nihon Naibunpi Gakkai Zasshi. 1992;68:1215–23.

    CAS  PubMed  Google Scholar 

  47. Ashraf VV, Bhasi R, Kumar RP, Girija AS. Primary Sjögren’s syndrome manifesting as multiple cranial neuropathies: MRI findings. Ann Indian Acad Neurol. 2009;12:124–6. doi:10.4103/0972-2327.53083.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Ebert EC. Gastrointestinal and hepatic manifestations of Sjogren syndrome. J Clin Gastroenterol. 2012;46:25–30. doi:10.1097/MCG.0b013e3182329d9c.

    Article  CAS  PubMed  Google Scholar 

  49. Corsiero E, Sutcliffe N, Pitzalis C, Bombardieri M. Accumulation of self-reactive naïve and memory B cell reveals sequential defects in B cell tolerance checkpoints in Sjögren’s syndrome. PLoS ONE. 2014;. doi:10.1371/journal.pone.0114575.

    PubMed  PubMed Central  Google Scholar 

  50. Jin L, Yu D, Li X, Yu N, Li X, Wang Y, et al. CD4+ CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren’s syndrome. Int J Clin Exp Pathol. 2014;7:1988–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Varin M-M, Guerrier T, Devauchelle-Pensec V, Jamin C, Youinou P, Pers J-O. In Sjögren’s syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev. 2012;11:252–8. doi:10.1016/j.autrev.2011.10.005.

    Article  CAS  PubMed  Google Scholar 

  52. Routsias JG, Tzioufas AG. Autoimmune response and target autoantigens in Sjogren’s syndrome. Eur J Clin Invest. 2010;40:1026–36. doi:10.1111/j.1365-2362.2010.02342.x.

    Article  CAS  PubMed  Google Scholar 

  53. Kyriakidis NC, Kapsogeorgou EK, Tzioufas AG. A comprehensive review of autoantibodies in primary Sjögren’s syndrome: clinical phenotypes and regulatory mechanisms. J Autoimmun. 2014;51:67–74. doi:10.1016/j.jaut.2013.11.001.

    Article  CAS  PubMed  Google Scholar 

  54. Gong Y-Z, Nititham J, Taylor K, Miceli-Richard C, Sordet C, Wachsmann D, et al. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren’s syndrome. J Autoimmun. 2014;51:57–66. doi:10.1016/j.jaut.2013.11.003.

    Article  CAS  PubMed  Google Scholar 

  55. Ittah M, Miceli-Richard C, Eric Gottenberg J-, Lavie F, Lazure T, Ba N, et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren’s syndrome. Arthritis Res Ther. 2006;8:R51. doi:10.1186/ar1912.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Barrera MJ, Bahamondes V, Sepúlveda D, Quest AFG, Castro I, Cortés J, et al. Sjögren’s syndrome and the epithelial target: a comprehensive review. J Autoimmun. 2013;42:7–18. doi:10.1016/j.jaut.2013.02.001.

    Article  CAS  PubMed  Google Scholar 

  57. Mostafa S, Seamon V, Azzarolo AM. Influence of sex hormones and genetic predisposition in Sjögren’s syndrome: a new clue to the immunopathogenesis of dry eye disease. Exp Eye Res. 2012;96:88–97. doi:10.1016/j.exer.2011.12.016.

    Article  CAS  PubMed  Google Scholar 

  58. Czerwinski S, Mostafa S, Rowan VS, Azzarolo AM. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren’s Syndrome: the influence of sex hormones and genetic background. Exp Eye Res. 2014;128:15–22. doi:10.1016/j.exer.2014.09.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Tsinti M, Kassi E, Korkolopoulou P, Kapsogeorgou E, Moutsatsou P, Patsouris E, et al. Functional estrogen receptors alpha and beta are expressed in normal human salivary gland epithelium and apparently mediate immunomodulatory effects. Eur J Oral Sci. 2009;117:498–505. doi:10.1111/j.1600-0722.2009.00659.x.

    Article  CAS  PubMed  Google Scholar 

  60. Manoussakis MN, Tsinti M, Kapsogeorgou EK, Moutsopoulos HM. The salivary gland epithelial cells of patients with primary Sjögren’s syndrome manifest significantly reduced responsiveness to 17β-estradiol. J Autoimmun. 2012;39:64–8. doi:10.1016/j.jaut.2012.01.005.

    Article  CAS  PubMed  Google Scholar 

  61. Katsiougiannis S, Tenta R, Skopouli FN. Endoplasmic reticulum stress causes autophagy and apoptosis leading to cellular redistribution of the autoantigens Ro/Sjögren’s syndrome-related antigen A (SSA) and La/SSB in salivary gland epithelial cells. Clin Exp Immunol. 2015;181:244–52. doi:10.1111/cei.12638.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Kang YK, Jung SY, Qin J, Li C, Tsai SY, Tsai M-J, et al. E2/Estrogen receptor/sjogren syndrome-associated autoantigen relieves coactivator activator-induced G1/S arrest to promote breast tumorigenicity. Mol Cell Biol. 2014;34:1670–81. doi:10.1128/MCB.01564-13.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We owe a special thank to Dr A. Garnier (Pathological laboratory, Montpellier), Pr Jean-Emmanuel Kahn (Internal Medicine, Foch Hospital, Suresnes, France), Pr Marc Michel (Internal medicine department, Mondor Hospital, Crétéil, France), all the Pathological department laboratory technicians (Montpellier Hospital) and A Nadaradjane for their kindly help in this work.

Authors Contribution

Radjiv Goulabchand (RG) and Philippe Guilpain (PG) conceived this study. Radjiv Goulabchand (RG), Assia Hafidi (AH), and Hélène Perrochia (HP) performed the histological analysis and captures. Radjiv Goulabchand (RG), Assia Hafidi (AH), Hélène Perrochia (HP), and Philippe Guilpain (PG) conducted interpretation and analysis. Radjiv Goulabchand (RG), Hélène Perrochia (HP), Assia Hafidi (AH), and Philippe Guilpain (PG) contributed to drafting the manuscript. Philippe Guilpain, Ingrid Millet, Jacques Morel, Cédric Lukas, Sébastien Humbert, Sophie Rivière, Christian Gény, Christian Jorgensen, and Alain Le Quellec have taken part in recruiting patients and collecting data. All authors have taken part in drafting the article or revising it critically for important intellectual content and final approval of the version to be published.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philippe Guilpain.

Ethics declarations

Conflict of interest

None of the authors has conflicting financial interests or grant support concerning this topic.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goulabchand, R., Hafidi, A., Millet, I. et al. Mastitis associated with Sjögren’s syndrome: a series of nine cases. Immunol Res 65, 218–229 (2017). https://doi.org/10.1007/s12026-016-8830-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-016-8830-x

Keywords

Navigation